Should EGFR TKI Therapy be Continued Beyond Progression?

Spreaker is getting a new look!

Preview our new listening experience personalized just for you.

Should EGFR TKI Therapy be Continued Beyond Progression?

GRACEcast

00:00

02:51

Like Download

Dr. Greg Riely, medical oncologist from MSKCC, discusses the controversial question of whether patients should continue on an oral EGFR tyrosine kinase inhibitor after progression.

Dr. Greg Riely, medical oncologist from MSKCC, discusses the controversial question of whether patients should continue on an oral EGFR tyrosine kinase inhibitor after progression. read more read less

8 years ago #adenocarcinoma, #advanced, #beyond, #cancergrace, #egfr, #factor, #grace, #greg, #growth, #impress, #isolated, #lung, #memorial, #mutation, #neversmoker, #nsclc, #progression, #resistance, #treatment, #trial

0 Comments

This episode has no messages yet. Be the first to write a message!

Spreaker is getting a new look!

Should EGFR TKI Therapy be Continued Beyond Progression?

Should EGFR TKI Therapy be Continued Beyond Progression?

0 Comments

For Creators

For Listeners & Advertisers

Choose Language

Follow us